Catalyst Pharmaceuticals (NASDAQ: CPRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) through any online brokerage.
The latest price target for Catalyst Pharmaceuticals (NASDAQ: CPRX) was reported by HC Wainwright & Co. on Tuesday, February 8, 2022. The analyst firm set a price target for 12.00 expecting CPRX to rise to within 12 months (a possible 60.21% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $7.49 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.